338
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Combination therapy of sodium–glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences

&
Pages 229-240 | Received 11 Oct 2015, Accepted 19 Nov 2015, Published online: 25 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

André J. Scheen. (2017) Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes. Expert Review of Clinical Pharmacology 10:12, pages 1303-1316.
Read now

Articles from other publishers (6)

Awadhesh Kumar Singh, Akriti Singh & Ritu Singh. (2023) Cardiovascular and Renal Outcomes With Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Combination Therapy: A Meta-Analysis of Randomized Cardiovascular Outcome Trials. Endocrine Practice 29:7, pages 509-516.
Crossref
Eun Jeong Ko, Yoo Jin Shin, Sheng Cui, Sun Woo Lim, Byung Ha Chung & Chul Woo Yang. (2022) Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus-induced diabetes mellitus and nephrotoxicity in a rat model. American Journal of Transplantation 22:6, pages 1537-1549.
Crossref
Kristy T. K. Lau, Carlos K. H. Wong, Ivan C. H. Au, Wallis C. Y. Lau, Kenneth K. C. Man, Celine S. L. Chui & Ian C. K. Wong. (2022) Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors. Journal of the American Heart Association 11:7.
Crossref
Awadhesh Kumar Singh, Ambika G. Unnikrishnan, Abdul H. Zargar, Ajay Kumar, Ashok K. Das, Banshi Saboo, Binayak Sinha, Kalyan Kumar Gangopadhyay, Pradeep G. Talwalkar, Samit Ghosal, Sanjay Kalra, Shashank Joshi, Surendra Kumar Sharma, Usha Sriram & Viswanathan Mohan. (2019) Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians. Diabetes Therapy 10:2, pages 393-428.
Crossref
Hao Liu, Yun Hu, Feng-fei Li, Bing-li Liu, Xiao-fei Su & Jian-hua Ma. (2016) Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin. Diabetes Therapy 7:4, pages 743-753.
Crossref
Heidi Storgaard, Lise L. Gluud, Cathy Bennett, Magnus F. Grøndahl, Mikkel B. Christensen, Filip K. Knop & Tina Vilsbøll. (2016) Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLOS ONE 11:11, pages e0166125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.